1. European Medicines Agency. Reflection paper on methodological issues in confirmatory clinical trials planned with an adaptive design. 2007. http://www.emea.europa.eu/pdfs/human/ewp/245902enadopted.pdf. Accessed October 18, 2007.
2. US Food and Drug Administration. Draft guidance for industry: adaptive design clinical trials for drugs and biologics. February 2010. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM201790.pdf.
3. Ellenberg S, Fleming T, DeMets D. Data Monitoring Committees in Clinical Trials: A Practical Perspective. New York, NY: Wiley; 2002.
4. US Food and Drug Administration. Guidance for clinical trial sponsors on the establishment and operation of clinical trial data monitoring committees. March 2006. http://www.fda.gov/downloads/Regulatoryinformation/Guidances/ucm127073.pdf.
5. European Medicines Agency. Guideline on data monitoring committees. 2006. July 27, 2005. http://www.emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003635.pdf.